New Jersey S4054 clarifies that testosterone therapy is a covered treatment under the "New Jersey Menopause Coverage Act.
New Jersey S4054 amends the "New Jersey Menopause Coverage Act" to ensure that testosterone therapy is covered as a treatment for women diagnosed with perimenopause or menopause. The bill mandates that benefits for testosterone therapy be provided to the same extent as for any other hormonal treatment and prohibits denial of coverage if the therapy is not FDA-approved for perimenopause or menopause.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.